News & Media :: Vedanta Biosciences, Inc.

May 8, 2023

Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week

Recent News

Apr 25, 2023

Pfizer-backed Vedanta Biosciences lands $106M for PhIII in C. diff, PhII in IBD

Apr 25, 2023

Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies

Apr 17, 2023

Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMID

Nov 24, 2022

Seeking therapeutic opportunities amid the complexity of the microbiome

View All News View All Press Releases